ONDANSETRON HYDROCH

The Defense Logistics Agency awarded a delivery order under the master contract SPE2DX-25-D-9900 to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0) for the supply of Ondansetron Hydrochloride, identified by NSN 6505015786170, with a total contract value of $20.94. The order, issued as SPE2DP26F7690 on July 15, 2026, requires delivery of two packages of the pharmaceutical product to Fort Bragg, NC, by July 30, 2026, under FOB Destination terms, with the contractor responsible for all shipping costs and logistics. The contractor is certified as a Women-Owned Small Business and must comply with strict packaging requirements, including shipment via traceable means only—parcel post is prohibited—and all packages must bear identification numbers from the contract in block printing. Inspection and acceptance occur at the destination, with the government responsible for confirming conformance to contract terms. The payment process is administered by DEF FIN AND ACCOUNTING SVC in Columbus, OH, under Payment Code SL4701, with DLA Troop Support in Philadelphia serving as the issuing office and administrative contact. No standard FAR clauses, MIL-STDs, or special contract requirements beyond packaging, delivery, and substitution rules are explicitly included; substitution of the product is permitted under the specified rank. The contract contains no options, variations, or performance periods beyond the single delivery, and no COR or COTR is named. All administrative and logistical requirements are minimal but tightly controlled, reflecting a routine pharmaceutical supply transaction under a pre-established DLA blanket purchase agreement.